2026年上半年中国种业上市公司营收规模分化、盈亏各半
一、核心数据总览 根据2026年上半年十家种子行业上市公司披露的财务数据,行业整体呈现「营收规模分化、盈亏各半」的格局。十家公司合计实现营业收入95.73亿元,合计净利润为-1.04亿元,行业整体处于微亏状态。从盈利面来看,盈利企业与亏损企…
华南农大在多倍体水稻创制和育性调控机理方面取得系列进展
大农化网报道:华南农业大学农学院刘向东教授团队围绕多倍体水稻创制和育性调控机理研究,连续发表了4篇研究成果,另有2项发明专利获得授权。4篇论文分别发表于Journal of Integrative Plant Biology(2篇)、Pla…
总投资3000万元,800吨哒螨灵及其600吨中间体生产线拟建
大农化网报道:近日,武威艾诺化学科技有限公司年产1200吨顺丁烯二酸二乙酯及2000吨O,O-二甲基二硫代磷酸酯项目、800吨哒螨灵项目环评受理公示。 为进一步满足市场需求,提升企业竞争力,武威艾诺化学科技有限公司拟投资建设本项…
东营举办多期主要粮油作物单产提升和秋粮作物机收减损技术培训
为强化粮食机收减损技术的普及与应用,提升广大农机手在生产实践中操作技能水平,为乡村振兴努力培养造就一批结构合理、技艺精湛的农机化实用人才队伍。近期,山东省东营市东营区举办多期主要粮油作物单产提升和秋粮作物机收减损技术培训,助力三秋生产顺…
兴发集团:草甘膦开工率保持正常,预计价格随需求季节性回暖稳中有升
大农化网报道:近日,湖北兴发化工集团股份有限公司(简称″兴发集团″)举行2026年半年度业绩说明会,公司董事长李国璋,独立董事郭月梅,董事、副总经理、财务负责人王琛和董事会秘书鲍伯颖出席与投资者交流,主要问答与回复内容如下: 1、请问定增项…
Lubrizol spots holistic shift toward proactive beauty and healthy aging in APAC women
Lubrizol has released a white paper showing that women in the Asia Pacific (APAC) region, particularly China, increasingly see beauty as something to maintain proactively rather than react to once problems appear. The demographic is also increasingly associating beauty with internal health, contributing to a growing beauty-from-within space.
Seppic launches vegan squalane polymer for clean beauty formulations
Seppic has launched Sepilife Neos, a patented liquid polymer based on natural-origin, which is traditionally sourced from shark liver oil. The vegan squalane expands the company’s Sepilife hybrid polymer range and is part of a larger industry move away from animal-derived ingredients.
Lilly’s GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders
Eli Lilly presented early positive clinical data supporting once-weekly dosing for its GIP/GLP-1 receptor agonist candidate brenipatide in substance use, psychiatric, and immunologic disorders—and detailed the design of Phase III trials that will assess the drug in major depressive disorder (MDD) and alcohol use disorder (AUD).
Matisse raises €14M for Phase 2 sepsis trial
Why it matters: Sepsis remains a major unmet need in critical care, with no approved treatment specifically targeting the dysregulated immune response that can lead to organ failure. Matisse is developing isupartob to intervene in that process by neutralizing extracellular histones.
拜耳领投!Robigo以RNAi+工程菌打造″田间生物工厂″,一次施用护全季
2026年9月17日,美国初创公司Robigo宣布,其A轮融资由拜耳投资部门Leaps by Bayer领投,Illumina Ventures、SVG Thrive、Congruent Ventures和Endeavor8参与投资。拜耳此…
